Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 6, 2010

View Archived Issues

New mechanism of action of AN-3365 linked to potent activity in Gram-negative bacterial infections

AVL-292 shows promise in models of arthritis and cancer and enters clinical development

Lipideon Biotechnology claims new cholesterol absorption inhibitors

Novartis discontinues development of albinterferon alfa-2b and Mycograb

Phase II data reported on Cevira in patients with mild cervical abnormalities

Zabofloxacin shows cardiac safety in phase I trial in healthy subjects

AS-2041835 and micafungin show synergistic antifungal activity in preclinical study

Phase II rasagiline trial in parkinsonian multiple system atrophy / News in Context

Daiichi Sankyo launches gel formulation of Loxonin in Japan

Lundbeck acquires exclusive rights to KW-6356 from Kyowa Hakko Kirin

Brain Factory gains Japanese rights to Eisai's ravuconazole prodrug

Human Genome Sciences and Novartis halt Zalbin development for HCV infection

Reviva Pharma claims new ligands of dopamine D2 receptor and serotonin receptors 5-HT1A/2A

Ambit Biosciences presents new inhibitors of JAK2 and JAK3

Pfizer describes new antagonists of calcium-sensing CaS receptor

Glenmark Pharma identifies new TRPM8 channel antagonists

FDA extends Xifaxan sNDA PDUFA goal date by 3 months

ProteoTech and Tasly collaborate on Exebryl-1 for Alzheimer's disease

Teva provides update on status of BLA for Neutroval in neutropenia

FDA approves Kapvay for use with stimulant medication for ADHD

Meda acquires erectile dysfunction therapy Muse from Vivus

Noven acquires Daytrana methylphenidate transdermal system from Shire

Enrollment complete for phase III trial of AG200-15 contraceptive patch

DSP and SanBio develop new stem cell therapy for stroke

Evotec and Shionogi form multiple-target drug discovery alliance

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...